Wilson Susan, Brömme Dieter
Department of Oral Biological and Medical Sciences, Faculty of Dentistry, University of British Columbia, Vancouver, Canada.
J Pediatr Rehabil Med. 2010;3(2):139-46. doi: 10.3233/PRM-2010-0116.
Cathepsin K, a papain-like cysteine protease, is highly expressed in osteoclasts and plays a critical role in bone resorption. Dysfunction of the enzyme leads to various skeletal abnormalities. The recent knowledge that the collagenolytic activity of cathepsin K depends on interactions with bone and cartilage-resident glycosaminoglycans (GAGs) may shed some light on diseases such as mucopolysaccharidoses (MPSs). MPSs are a group of lysosomal storage diseases characterized by the accumulation of GAGs in tissues including bone. Typical pathological features of these diseases include skeletal abnormalities such as dysostosis multiplex, short stature, and multiple irregularities in bone development. We describe how further investigation of the cathepsin K/GAG complexes could provide valuable insights into the bone pathology associated with MPS diseases. In this review, we discuss the inhibition of osteoclast function through altered activity of cathepsin K by GAGs and offer insight into a mechanism for the bone pathology seen in MPS patients.
组织蛋白酶K是一种木瓜蛋白酶样半胱氨酸蛋白酶,在破骨细胞中高度表达,在骨吸收中起关键作用。该酶功能异常会导致各种骨骼异常。最近发现组织蛋白酶K的胶原olytic活性取决于与骨和软骨驻留糖胺聚糖(GAG)的相互作用,这可能为诸如黏多糖贮积症(MPS)等疾病提供一些线索。MPS是一组溶酶体贮积病,其特征是GAG在包括骨在内的组织中蓄积。这些疾病的典型病理特征包括骨骼异常,如多发性骨发育异常、身材矮小和骨发育中的多种异常。我们描述了对组织蛋白酶K/GAG复合物的进一步研究如何能够为与MPS疾病相关的骨病理学提供有价值的见解。在这篇综述中,我们讨论了通过GAG改变组织蛋白酶K的活性来抑制破骨细胞功能,并深入探讨了MPS患者所见骨病理学的机制。